7-Deazapurine 2′-deoxyribofuranosides are noncleavable competitive inhibitors of Escherichia coli purine nucleoside phosphorylase (PNP)

Acta Biochimica Polonica

Volumn 45, Issue 3, 1998, Pages 755-768

  Bzowska, Agnieszka ^a   Kazimierczuk, Zygmunt ^a   Seela, Frank ^b  

^a UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

7 deazapurine nucleosides; E. Coli, cladribine; Inhibitors; Phosphorylase; Tubercidin

Indexed keywords

ESCHERICHIA COLI;

DEOXYADENOSINE DERIVATIVE; ENZYME INHIBITOR; PURINE NUCLEOSIDE PHOSPHORYLASE;

ARTICLE; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; ESCHERICHIA COLI; ISOLATION AND PURIFICATION; METABOLISM;

DEOXYADENOSINES; ENZYME INHIBITORS; ESCHERICHIA COLI; PURINE-NUCLEOSIDE PHOSPHORYLASE; SUBSTRATE SPECIFICITY;

EID: 0032246848     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.1998_4269     Document Type: Article

References (51)

1. Beulter, E. (1992) Cladribine (2-chlorodeoxyadenosine). Lancet 340, 952-956.
2. Bryson, H.M. & Sorkin, E.M. (1993) Cladribine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in hematological malignancies. Drugs 46, 872-894.
3. Sipe, J.C., Romine, J.S., Koziol, J.A., McMillan, R. & Beulter, E. (1994) Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 344, 9-13.
4. Carson, D.A., Wasson, D.B., Esparza, L.M., Carrera, C.J., Kipps, T.J. & Cattam, H.B. (1992) Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine. Proc. Natl. Acad. Sci. U.S.A. 89, 2970-2974.
5. Tarasiuk, A., Skierski, J. & Kazimierczuk, Z. (1994) Stability of 2-chloro-2′-deoxyadenosine at various pH and temperature. Arch. Immunol. Ther. Exp. 42, 13-15.
6. Bzowska, A. & Kazimierczuk, Z. (1995) Cladribine (2-CdA) and its analogues are good substrates and potent selective inhibitors of bacterial (Escherichia coli) purine nucleoside phosphorylase. Eur. J. Biochem. 233, 886-890.
7. Stoeckler, J.D., Ryden, J.B., Parks, R.E., Jr., Chu, M.Y., Lim, M.I., Ren, W.Y. & Klein, R.S. (1986) Inhibitors of purine nucleoside phosphorylase: Effects of 9-deazapurine ribonucleosides and synthesis of 5′-deoxy-5′-iodo-9-deazainosine. Cancer Res. 46, 1774-1778.
8. Stoeckler, J.D. (1984) Purine nucleoside phosphorylase: A target for chemotherapy; in Developments in Cancer Chemotherapy (Glazer, R.J., ed.) pp. 35-60, CRC Press Inc., Boca Raton.
9. Bzowska, A., Kulikowska, E. & Shugar, D. (1992) Formycins A and B and some analogues: Selective inhibitors of bacterial (E. coli) purine nucleoside phosphorylase. Biochim. Biophys. Acta 1120, 239-247.
10. Doskočil, J. & Holý, A. (1977) Specificity of purine nucleoside phosphorylase from Escherichia coli. Coll. Czech. Chem. Commun. 42, 370-383.
11. Ohkuma, K. (1960) Chemical structure of toyocamycin. J. Antibiotics 13A, 361-363.
12. Bzowska, A., Kulikowska, E. & Shugar, D. (1993) Linear free energy relationships for N(7)-substituted guanosines as substrates of calf spleen purine nucleoside phosphorylase. Possible role of N(7) protonation as a catalytic mechanism. Z. Naturforsch. 48c, 803-811.
13. Kline, P.C. & Schramm, V.L. (1993) Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction. Biochemistry 32, 13212-13219.
14. Erion, M.D., Stoeckler, J.D., Guida, W.C., Walter, R.L. & Ealick, S.E. (1997) Purine nucleoside phosphorylase. 2. Catalytic mechanism. Biochemistry 36, 11735-11748.
15. Bhuyan, B.K., Renis, H.E. & Smith, C.G. (1962) A collagen plate assay for cytotoxic agents. II. Biological studies. Cancer Res. 22, 1131-1136.
16. Duvall, L.R. (1963) Tubercidin. Cancer Chemother. Rept. 30, 61-62.
17. Owen, S.P. & Smith, C.G. (1964) Cytotoxicity and antitumor properties of the abnormal nucleoside tubercidin and related compounds. Cancer Res. 36, 19-20.
18. Saneyoshi, M., Tokuzen, R. & Fukuoka, F. (1965) Anti-tumor activities and structural relationship of tubercidin, toyocamycin and their derivatives. Gann. 56, 219-225.
19. Smith, C.G., Lummis, W.L. & Grady, J.E. (1959) An improved tissue culture assay. II. Cytotoxicity studies with antibiotics, chemicals and solvents. Cancer Res. 19, 847-852.
20. Renis, H.E., Johnson, H.G. & Bhuyan, B.K. (1962) A collagen plate assay for cytotoxic agents I. Methods. Cancer Res. 22, 1126-1130.
21. Grage, T.B., Rochlin, D.B., Weiss, A.J. & Wilson, W.L. (1970) Clinical studies with tubercidin administrated after absorption into human erythrocytes. Cancer Res. 30, 79-81.
22. Acs, G, Reich, E. & Mori, M. (1964) Biological and biochemical properties of the analogue antibiotic tubercidin. Proc. Natl. Acad. Sci. U.S.A. 52, 493-501.
23. Suzuki, S. & Marumo, S. (1961) Chemical structure of tubercidin. J. Antibiotics 14A, 34-38.
24. Mao, C., Cook, W.J., Zhou, M., Koszalka, G.W., Krenitsky, T.A. & Ealick, S.E. (1997) The crystal structure of Escherichia coli purine nucleoside phosphorylase: A comparison with the human enzyme reveals a conserved topology. Structure 5, 1373-1383.
25. Koellner, G., Luic, M., Shugar, D., Saenger, W. & Bzowska, A. (1998) Crystal structure of the ternary complex of E. coli purine nucleoside phosphorylase with formycin B, a structural analogue of the substrate inosine, and phosphate (sulphate) at 2.1 Å resolution. J. Mol. Biol. 280, 153-166.
26. Leonard, N.J. & Laursen, R.A. (1965) Synthesis of 3-β-D-ribofuranosyladenine and (3-β-D-ribofuranosyladenine)-5′-phosphate. Biochemistry 4, 354-365.
27. Seela, F. & Kehne, A. (1983) 2-Deoxytubercidin - Synthese eines 2-Deoxyadenosin -Isostern durch Phasetransferglycosylierung. Liebigs Ann. Chem. 876-884.
28. Kazimierczuk, Z., Revankar, G.T. & Robins, R.K. (1984) Total synthesis of certain 2-, 6- and 2,6-disubstituted tubercidin derivatives. Synthesis of tubercidin via the sodium salt glycosylation procedure. Nucleic Acids Res. 12, 1179-1192.
29. Seela, F., Driller, H. & Liman, U. (1985) 7-Deseaza-Isostere von 2′-Desoxyxanthosin und 2′-Desoxyspongosin - Synthese via Glycosylierung von 2,4-Dichlor-7H-pyrrolo[2,3-d]pyrimidin. Liebigs Ann. Chem. 312-320.
30. Seela, F., Menkhoff, S. & Behrendt, S. (1986) Furanoside-pyranoside isomerisation of tubercidin and its 2′-deoxy derivatives: Influence of nucleobase and sugar structure on the proton-catalyzed reaction. J. Chem. Soc. Perkin. Trans. 2, 525-530.
31. Seela, F., Stecker, H. Driller, H. & Bindig, U. (1987) 2-Amino-2′-desoxytubercidin und verwandte Pyrrolo[2,3-d]pyrimidinyl-2′-desoxyribofuranoside. Liebigs Ann. Chem. 15-19.
32. Seela, F., Soulimane, H., Mersmann, K. & Jurgens, T. (1990) 2,4-Disubstituted pyrrolo[2,3-d]pyrimidine α-D- and β-D-ribofuranosides related to 7-deazaguanosine. Helv. Chim. Acta 73, 1879-1887.
33. Seela, F. & Thomas, H. (1994) Synthesis of certain 5-substituted 2′-deoxytubercidin derivatives. Helv. Chim. Acta 77, 897-903.
34. Seela, F. & Zulauf, M. (1996) Palladium-catalyzed cross coupling of 7-iodo-2′-deoxytubercidin with terminal alkynes. Synthesis, 726-730
35. Kulikowska, E., Bzowska, A., Wierzchowski, J. & Shugar, D. (1986) Properties of two unusual, and fluorescent substrates of purine nucleoside phosphorylase: 7-Methylguanosine and 7-methylinosine. Biochim. Biophys. Acta 874, 355-363.
36. Bzowska, A., Kulikowska, E. & Shugar, D. (1990) Properties of purine nucleoside phosphorylase (PNP) of mammalian and bacterial origin. Z. Naturforsch. 45c, 59-70.
37. Schrader, W.P., Stacy, A.R. & Pollara, B. (1976) Purification of human erythrocyte adenosine deaminase by affinity column chromatography. J. Biol. Chem. 251, 4026-4032.
38. Lehikoinen, P.K., Sinnot, M.L. & Krenitsky, T.A. (1989) Investigation of α-deuterium kinetic isotope effects on the purine nucleoside phosphorylase reaction by the equilibrium-perturbation technique. Biochem. J. 257, 355-359.
39. Cook, W.J., Ealick, S.E., Krenitsky, T., Stoeckler, J.D., Helliwell, J.R. & Bugg, S.E. (1985) Crystallization and preliminary X-ray investigation of purine nucleoside phosphorylase form Escherichia coli. J. Biol. Chem. 260, 12968-12969.
40. Kalckar, H.M. (1947) Enzymatic synthesis of purine ribosides. J. Biol. Chem. 167, 477-486.
41. Stoeckler, J.D., Agarwal, R.P., Agarwal, K.C. & Parks, R.E., Jr. (1978) Purine nucleoside phosphorylase from human erythrocytes. Methods Enzymol. 51, 530-538.
42. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
43. Stoscheck, C.M. (1990) Quantitation of proteins. Methods Enzymol. 182, 50-68.
44. Hershfield, M.S., Chaffee, S., Koro-Johnson, L., Mary, A., Smith, A.A. & Short, S.A. (1991) Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol. Proc. Natl. Acad. Sci. U.S.A. 88, 7185-7189.
45. Jensen, K.F. & Nygaard, P. (1975) Purine nucleoside phosphorylase from Escherichia coli and Salmonella typhimurium. Purification and some properties. Eur. J. Biochem. 51, 253-265.
46. Dawson, R.M.C., Elliott, D., Elliott, W.H. & Jones, K.M. (1969) Data for Biochemical Research, pp. 58-61, Oxford University Press, Ely House, London.
47. Segal, I.H. (1975) Enzyme Kinetics. John Wiley and Sons, New York.
48. Keleti, T. (1986) Basic Enzyme Kinetics. Akademiai Kiado, Budapest.
49. Hammes, G.G. (1982) Enzyme Catalysis and Regulation. Academic Press.
50. Bzowska, A. Kulikowska, E., Shugar, D., Bingyi, C., Lindborg, B. & Johansson, N.G. (1991) Acyclonucleoside analogue inhibitors of mammalian purine nucleoside phosphorylase. Biochem. Pharmacol. 41, 1791-1803.
51. Bzowska, A. Kulikowska, E., Poopeiko, N.E. & Shugar, D. (1996) Kinetics of phosphorolysis of 3-(β-D-ribofuranosyl)adenine and 3-(β-D-ribofuranosyl)hypoxanthine, non-conventional substrates of purine nucleoside phosphorylase. Eur. J. Biochem. 239, 229-234.